Therini Bio
Phase 1Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $40M
About
Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
AntibodiesBiologics
Funding History
2Total raised:$40M
Series A$35MJan 15, 2022
Seed$5MApr 15, 2020